Britain’s health regulators have approved the world’s first pill to treat cases of symptomatic COVID-19. Medicines and Healthcare Products Regulatory Agency (MHRA) said, the antiviral molnupiravir has been found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19, who are at increased risk of developing the disease.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The Indian Space Research Organisation (ISRO) and the European Space Agency (ESA) have extended their…
England fast bowler Mark Wood announced his retirement from international cricket on September 22, 2026,…
The Indian women’s cricket team won the gold medal at the Asian Games 2026 after…
India has endorsed the consensus outcomes of the G20 Energy Abundance Ministerial, reinforcing its engagement…
The 7th edition of the National Formulary of India (NFI) 2026 was launched on September…
The Government of India has dissolved the Digital Communications Commission (DCC), the apex inter-departmental decision-making…